MYFClass II
Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
21 CFR 866.3305 / Microbiology
MYF is the FDA product code for Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2, a class II device type, regulated under 21 CFR 866.3305. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and 2 recalls.
Classification record
- Product code
- MYF
- Device name
- Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
- Regulation
- 21 CFR 866.3305
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 10
- Ingested recalls
- 2
Clearances, product code MYF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code MYF| Applicant | Clearances |
|---|---|
| Biokit, S.A. | 2 |
| Quest International, Inc. | 2 |
| Diasorin Inc. | 1 |
| Euroimmun US Inc. | 1 |
| Mrl Diagnostics | 1 |
| Roche Diagnostics GmbH | 1 |
| Trinity Biotech USA | 1 |
| Zeus Scientific LLC | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
